[PR] NEW STUDY LINKS THIMEROSAL (MERCURY) EXPOSURE WITH AUTISM

[Guest guest]

ALL,

RE: PRESS RELEASE

Attached is a CoMeD, Inc. PRESS RELEASE for a

new study linking Thimerosal(mercury) exposure

from Rho(D) products administered during preg-

nancy to neurodevelopmental disorders, including

autism, in the children born to these mothers.

RE: THOSE NOT ACCEPTING E-MAIL ATTACHMENTS

For those who do not get SUCH, the follow-

ing is the rough-text of the Press Release's

content:

>

>NEW STUDY LINKS THIMEROSAL (MERCURY)

>EXPOSURE WITH AUTISM

>

>PRESS RELEASE CONTACTS:

>For Immediate CoMeD President [Rev. K.

>Release Sykes (Richmond, VA) ]

>July 13, 2008 CoMeD Sci. Advisor [Dr. King

> (Lake Hiawatha, NJ) ]

>

>WASHINGTON, DC - A new peer-reviewed study,

> " Neurodevelopmental Disorders, Maternal

>Rh-Negativity, and Rho(D) Immune Globulins:

>A Multi-Center Assessment, " published in

>Neuroendocrinology Letters 2008; 29(2):

>272-280, found significant links between

>mercury exposure from Thimerosal-containing

>Rho(D) immune globulin preparations and

>the neurodevelopmental disorder diagnoses

>found in the affected children studied.

>

>Furthermore, the study found links to

>autism spectrum disorders and attention-

>deficit-/attention-deficit-hyperactivity-

>disorders.

>

>This new study was based on two hypo-

>theses:

>1. IF prenatal exposure to Rho(D)-immune

> globulin was a risk factor for neuro-

> developmental disorders, THEN more

> children with a neurodevelopmental

> disorder (ND) would have Rh-negative

> mothers compared than a similar group

> of children born to Rh-positive

> mothers (a control group).

>2. IF the Thimerosal in some Rho(D)-

> immune globulin preparations was

> the main risk factor for neurode-

> velopmental disorders, THEN, fol-

> lowing the removal of Thimerosal

> from all manufactured Rho(D)-immune

> globulin preparations distributed

> in the US (from 2002 onwards), the

> frequency of maternal Rh-negativity

> among children with an ND should be

> similar to that for the control

> groups.

>

>To test these, maternal Rh-negativity

>was assessed at two clinics (Clinic A-

>Lynchburg, VA; Clinic B-Rockville and

>Baltimore, MD) among 298 Caucasian

>children with an ND and known Rh-status.

>As controls, maternal Rh-negativity

>frequency was determined at Clinic A

>from 124 Caucasian children (born 1987-

>2001) without an ND. This maternal Rh-

>negativity frequency was also deter-

>mined from 1,021 Caucasian pregnant

>mothers that presented for prenatal

>genetic care at Clinic B (1980-1989).

>Additionally, 22 Caucasian patients

>with an ND, born from 2002 onwards

>(Clinics A and , were assessed for

>maternal Rh-negativity.

>

>This study found comparable, statis-

>tically significant increases in

>maternal Rh-negativity percentage

>among children with: a) an ND (Clin-

>ic: A=24.2%), an autism spectrum

>disorder (Clinic: A=28.3%, B=25.3%),

>or c) an attention-deficit-disorder/

>attention-deficithyperactivity-dis-

>order (Clinic: A=26.3%) in compari-

>son to both of the control groups

>(Clinic: A=12.1%, B=13.9%). Chil-

>dren with an ND, born after 2001,

>had a maternal Rh-negativity per-

>centage (13.6%), which was similar

>to the percentages for the two

>control groups.

>

>These results have clearly shown

>an association between: a) prena-

>tal Thimerosal exposure and

>the risk of children being diag-

>nosed with an ND.

>

>In addition, these findings call

>into question the safety of the

>current recommendation that preg-

>nant women be given an inacti-

>vated-influenza vaccine because

>most all of each year's vaccine

>doses still contain Thimerosal

>(49.55-wt% mercury) and the ma-

>jority are still Thimerosal-pre-

>served.

>

>Finally, this study was a multi-

>center collaborative effort

>lead by Mr. A. Geier of

>the Institute of Chronic Illnes-

>ses, Inc., and Dr.

>Mumper of the Advocates for

>Children Pediatrics, Ltd.

>

>Your generous tax-free donations

>will help us fund research to

>examine mercury's links to

>autism and other illnesses, de-

>fine the causal roles of mercury

>in the linked childhood and

>adult illnesses, and find appro-

>priate curative therapies.

>

>To support the ongoing efforts

>of CoMeD, Inc. with your tax-

>deductible contributions, please

>use the PayPal link on CoMeD's

>Internet website,

>http://www.mercury-freedrugs.org.

>CoMeD, Inc. is a not-for-profit

>501©(3) corporation that is

>actively engaged in legal,

>educational and scientific

>efforts to stop all use of

>mercury in medicine, and to ban

>the use of all mercury-containing

>medicines.

>

Hopefully, most will find this

>Press Release to be informative.

*******************************************

*The information provided in this email *

*and any attachment thereto is just that *

* -- information. *

* *

*It is not medical advice and it does not *

*require any specific action or actions. *

* *

*While the information is thought to be *

*accurate, no representation is made as *

*to the accuracy of the information posted*

*other than it is my best understanding of*

*the facts on the date that this email and*

*any attachments thereto are posted. *

* *

*Everyone should verify the accuracy of *

*the information provided for themselves *

*before acting on it. *

*******************************************

Respectfully,

Dr. King

http://www.dr-king.com

+++++++++++++++++++++++++++++++++++++++++++